Product Information
BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $10.0787 per ML under NDC 24208046415. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Aug 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208046415
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BRINZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204884FDA Approved
8/18/2021
TE Code
AB
On Market Since
3/31/2022
Pharmacological Classes
Price Statistics
The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0787 per ML |
|---|---|
| All-time high | $14.3013 (Feb 11, 2026) |
| All-time low | $10.0787 (Aug 19, 2026) |
| 52-week high | $14.3013 |
| 52-week low | $10.0787 |
| Median price | $11.5392 |
| Average price | $11.5635 |
| Largest weekly change | +14.5% (Jan 21, 2026) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $10.0787 per ML (NDC 24208046415), effective Aug 19, 2026.
How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 18.9%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?
Since Nov 5, 2025, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $10.0787 (Aug 19, 2026) to a high of $14.3013 (Feb 11, 2026), with a median of $11.5392 per ML.
Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $9.4893 per ML — about 6% below BRINZOLAMIDE 1% EYE DROPS.
Who manufactures BRINZOLAMIDE 1% EYE DROPS?
BRINZOLAMIDE 1% EYE DROPS (NDC 24208046415) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.